Infectious Diseases: Emerging Diagnostic Methods, Updated Treatment Protocols and New Antimicrobial Agents
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: closed (31 July 2024)
Special Issue Editors
2. Department of Microbiology, 'Saint Savvas' Oncology Hospital, 11635 Athens, Greece
Interests: clinical microbiology; infectious diseases; antimicrobial resistance; laboratory medicine; laboratory hematology; transfusion medicine; hemostasis; thrombosis; biostatistics
Special Issues, Collections and Topics in MDPI journals
Interests: orthopedics; musculoskeletal infections; hand surgery; musculoskeletal trauma; spine diseases
Special Issues, Collections and Topics in MDPI journals
Interests: neonatal sepsis; SARS-CoV-2; infectious diseases; neonatal sepsis diagnosis decision-making; inflammatory biomarkers; congenital infections; neonatal sepsis-associated coagulopathy
Special Issues, Collections and Topics in MDPI journals
Interests: epidemiology; respiratory medicine; pulmonary disease; pneumonia; lower respiratory infection; airways; risk of bias; prognosis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The COVID-19 pandemic has highlighted in the most prominent way the devastating impact of infections in healthcare systems across the world. Therefore, a thorough understanding of the pathogenetic mechanisms involved in bacterial, viral, and fungal infections is fundamental and may lead to the development of novel diagnostic methods and new treatment protocols. Over the past few decades, major advances in emerging diagnostic modalities based on molecular techniques have significantly improved the detective accuracy for various pathogens. With the advent of these molecular techniques, such as the next-generation sequencing, the sensitivity of the current diagnostic protocols has significantly increased, while the unique molecular properties of each pathogen allow for a more accurate identification of the isolated microorganism in any specimen. Other biomarkers such as the soluble tumor necrosis factor and the B-cell activating factor in musculoskeletal infections, or the peptide procalcitonin in respiratory infections, also have promising results and can help in detection of such infections, or in distinguishing bacterial from viral infections. Moreover, the devastating impact of increased microbial resistance due to the uncontrolled use of antibiotics has led to the development of multiresistant pathogens. These pathogens have increased the mortality rate of infected patients, especially in intensive care units. However, the development of novel antibiotic agents with extended coverage to these multiresistant pathogens has provided clinicians with additional options in their fight against these fatal infections.
Our target in this Special Issue is to present recent advances in diagnostic modalities and treatment protocols of infections in various fields of medicine, while also gathering up-to-date information on the risk factors, prognosis, and pathogenetic mechanisms that are involved in the development of infectious diseases. Basic research articles, observational studies, clinical trials, systematic reviews, meta-analyses, and narrative reviews on the topic of interest will be considered for this Special Issue.
Dr. Andreas G. Tsantes
Dr. Dimitrios V. Papadopoulos
Dr. Rozeta Sokou
Dr. Vanesa Bellou
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Dr. Andreas G. Tsantes
Dr. Dimitrios V. Papadopoulos
Dr. Rozeta Sokou
Dr. Vanesa Bellou
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- infectious diseases
- pathophysiology
- risk factors
- prognosis
- diagnostic methods
- biomarkers
- molecular techniques
- treatment protocols
- novel antibiotic
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
